Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)

Circulation. 2011 Sep 13;124(11):1250-9

Specifications

Google Plus
LinkedIn
ukidneyisup